Anixa Biosciences (ANIX) Income Statement: Revenue & Earnings

Anixa Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Anixa Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021	Oct 2020	Oct 2019	Oct 2018
Revenue & Gross Profit
Revenue	0.00	0.00	0.21	0.00	0.51	0.00	0.25	1.11
Cost of Revenue	0.04	0.00	0.16	0.00	0.39	9.98	-12.14	0.77
Gross Profit	-0.04	0.00	0.05	0.00	0.13	-9.98	0.25	0.34
Operating Expenses
Research & Development	5.07	6.40	4.77	6.70	6.19	4.38	5.47	6.81
Selling, General & Administrative	6.63	7.44	6.29	7.17	7.07	5.60	5.66	6.91
Operating Expenses	11.67	13.83	11.06	13.88	13.26	9.98	11.72	14.05
Operating Income	-11.70	-13.83	-11.01	-13.88	-13.14	-9.98	-11.47	-13.71
Other Income/Expense
Interest Income	0.67	1.13	1.08	0.10	0.00	0.03	0.00	0.05
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.67	0.00	0.00	0.00	0.01	0.15	0.42	-0.58
Income
Income Before Tax	-11.03	-12.70	-9.93	-13.77	-13.13	-10.09	-11.82	-14.24
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	-0.80	-1.94	0.00
Net Income	-10.93	-12.55	-9.81	-13.60	-12.95	-10.02	-11.65	-14.00
Net Income - Continuous Operations	-10.93	-12.70	-9.93	-13.77	-13.13	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-11.70	-13.79	-10.97	-13.83	-13.10	-9.89	-11.35	-13.36
EBIT	-11.70	-13.83	-11.01	-13.88	-13.14	-9.98	-11.82	-13.71
Depreciation & Amortization	0.04	0.04	0.05	0.04	0.04	-0.04	0.42	0.33
Earnings Per Share
Basic EPS	-	-	-	-	-	-	-	-1.00
Diluted EPS	-	-	-	-	-	-	-1.00	-1.00
Basic Shares Outstanding	32.45	31.90	30.98	30.37	28.58	22.23	19.79	17.62
Diluted Shares Outstanding	32.45	31.90	30.98	30.37	28.58	22.23	19.74	17.62